1. Translating RNA sequencing into clinical diagnostics: opportunities and challenges
    Sara A. Byron et al, 2016, Nature Reviews Genetics CrossRef
  2. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer
    Stefania Morganti et al, 2019, Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics CrossRef
  3. The application of RNA sequencing in precision cancer medicine
    Uttara Saran et al, 2024, Comprehensive Precision Medicine CrossRef
  4. aRrayLasso: a network-based approach to microarray interconversion
    Adam S. Brown et al, 2015, Bioinformatics CrossRef
  5. Screening of BRCA1/2 deep intronic regions by targeted gene sequencing identifies the first germline BRCA1 variant causing pseudoexon activation in a patient with breast/ovarian cancer
    Gemma Montalban et al, 2019, Journal of Medical Genetics CrossRef
  6. Advances in understanding the molecular pathology of gynecological malignancies: the role and potential of RNA sequencing
    Alba Southern et al, 2021, International Journal of Gynecologic Cancer CrossRef
  7. Improving Genetic Testing in Hereditary Cancer by RNA Analysis
    Paula Rofes et al, 2020, The Journal of Molecular Diagnostics CrossRef
  8. From bulk, single-cell to spatial RNA sequencing
    Xinmin Li et al, 2021, International Journal of Oral Science CrossRef
  9. Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing
    R. Scarpitta et al, 2019, Breast Cancer Research and Treatment CrossRef
  10. BRCA1 and BRCA2 whole cDNA analysis in unsolved hereditary breast/ovarian cancer patients
    Gemma Montalban et al, 2021, Cancer Genetics CrossRef
  11. Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer
    Anna Jasiak et al, 2023, Experimental and Molecular Pathology CrossRef
  12. Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology
    Ye Wang et al, 2020, Frontiers in Oncology CrossRef
  13. No Evidence for the Pathogenicity of the BRCA2 c.6937 + 594T>G Deep Intronic Variant: A Case–Control Analysis
    Julie Dutil et al, 2018, Genetic Testing and Molecular Biomarkers CrossRef
  14. Emerging technologies for salivaomics in cancer detection
    Karolina Elżbieta Kaczor‐Urbanowicz et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
  15. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools
    Nancy Martínez-Montiel et al, 2017, Genes CrossRef